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Background:  Understanding  public  opinion  and  attitudes  regarding  vaccination  is  crucial  for  successful
outbreak  management  and  effective  communication  at  the European  level.
Methods:  We  explored  national  differences  by conducting  focus  group  discussions  in  The  Netherlands,
Poland  and Sweden.  Discussions  were  structured  using  concepts  from  behavioural  models.
Results:  Thematic  analysis  revealed  that  participants  would  base  their  vaccination  decision  on  trade-
offs  between  perceived  beneﬁts  and  barriers  of  the  vaccine  also  taking  into  account  the seriousness
of  the  new  outbreak.  Except  for those  having  chronic  diseases,  participants  expected  a  low  infection
risk,  resulting  in  a low willingness  to  get  vaccinated.  Information  about  the  health  status  of  cases  was
considered  important  since  this  might  change  perceived  susceptibility.  Participants  displayed  concerns
about  vaccine  safety  due to  the  limited  available  time  to  produce  and  test  vaccines  in  the  acute  situation
of  a  new  pandemic.  Swedish  participants  mentioned  their tendency  of  doing  the  right  thing  and  following
the  rules,  as well  as  to  get  vaccinated  because  of solidarity  with  other  citizens  and  social  inﬂuences.  This
appeared  much  less  prominent  for  the  Dutch  and  Polish  participants.  However,  Swedish  participants
indicated  that  their negative  experiences  during  the  Inﬂuenza  A/H1N1  2009 pandemic  decreases  their
acceptance  of  future  vaccinations.  Polish  participants  lacked  trust  in  their  national  (public)  health  system
and government,  and  were therefore  sceptical  about  the  availability  and  quality  of  vaccines  in  Poland.
Conclusions:  Although  participants  overall  expressed  similar  considerations,  important  differences
between  countries  stand  out, such  as  previous  vaccination  experiences,  the  degree  of  adherence  to  social
norms,  and  the degree  of trust in  health  authorities.
©  2016  The  Authors.  Published  by  Elsevier  Ltd.  This  is  an  open  access  article  under the  CC  BY license. IntroductionOutbreaks of communicable diseases will cross borders, with
nﬂuenza A/H1N1 [1] and Ebola [2] being recent examples, and
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increased international travel and migration will facilitate their
speed and spread [3]. Cross-border collaboration in the manage-
ment of future outbreaks within Europe is therefore necessary.
Since public health professionals and authorities will be focused
on controlling the spread and impact of the new disease during
such an outbreak [4], it is essential to timely update and improve
existing European pandemic preparedness plans, preferably before
outbreaks begin [5].
The success of mitigating a new outbreak is largely dependent
on the willingness of the public to comply with recommended
preventive measures. Understanding the public opinion and atti-
tudes regarding preventive measures is thus crucial for successful
outbreak management and effective communication. Reasons to
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Table 1
Summary of participants’ characteristics (n = 41).
Dutch participantsa (n = 17) Polish participantsa (n = 12) Swedish participantsa (n = 12)
Median age in years (range) 47 (22–77) 46 (19–61) 40 (21–80)
Female 8/17 6/12 6/12
Low  educational levelb 12/17 6/12 8/12
Having children 9/17 8/12 3/12
Belonging to risk group 8/17 2/12 2/12
If  yes, seasonal inﬂuenza vaccine 7/8 0/2 1/2
Vaccinated against H1N1 9/17 0/12 10/12
Preventive measures against H1N1, other than vaccination 4/17 2/12 9/12
If  yes, type of preventive measuresc
Hygiened 4/4 2/2 6/9
Use  nose-mouth mask – – 1/9
Avoid travelling abroad – – 1/9
Avoid crowded places – – 1/9
Not  speciﬁed – – 3/9
a We conducted two  focus group discussions in The Netherlands with nine and eight participants, respectively. In Poland and in Sweden six persons participated per
discussion.
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sb In all countries, high educational level was deﬁned as tertiary education; all oth
c Some participants stated that they applied multiple measures.
d Hygiene includes washing hands more often, use hand sanitizer, cleaning deskt
ccept or decline preventive measures in pandemic situations have
een described [4,6–12], but very little is known about potential
ifferences herein across Europe.
We  therefore conducted focus group discussions in three
ountries across Europe to explore (1) the public opinion and atti-
ude regarding future pandemics and vaccination and (2) potential
ifferences in opinions and attitudes between participants in The
etherlands, Sweden, and Poland.
. Methods
We  opted for focus group discussions (FGDs) [13,14] to explore
ublic opinion and attitudes. FGDs were chosen because these
nable unforeseen topics to arise and to be explored in depth
15]. We  developed a theory based semi-structured question route
ased on the Health Belief Model and two elements from other
ehavioural models (Supplementary ﬁles A and B). The question
oute was pilot tested, evaluated and improved where necessary.
The Medical Ethics Committee of the Erasmus Univer-
ity Medical Center Rotterdam approved the study protocol
MEC-2012-263). Independent research agencies recruited 6–9
articipants per FGD and used purposive sampling methods to
nsure a diverse sample regarding age, sex, and educational level.
articipants received a ﬁnancial incentive for their contribution,
dapted to the national norm.
In each country, moderators trained in performing qualitative
esearch conducted two FGDs in large cities in 2012. One of the
uthors (DD) debriefed the Polish and Swedish moderators before
he discussion about background of the study and the question
oute. All participants gave written informed consent prior to the
iscussions. FGDs lasted for approximately 90 min  and were con-
ucted in the native language. All FGDs were audio taped and ﬁeld
otes were made during each discussion. At the end of the FGDs all
articipants completed a short questionnaire on socio demograph-
cs and previous experiences with preventive measures.
The discussions were transcribed verbatim and identiﬁable data
as removed. The entire Swedish and Polish transcripts, and the
elected Dutch quotes were translated into English. A thematic
nalysis was performed [14,16]. First, two authors (DD and IK)
ndependently read all transcripts in-depth. Second, they created
 provisional coding tree, based on the themes that emerged from
he data. Third, they each identiﬁed and coded relevant text pas-
ages in one transcript per country and reﬁned the coding tree.
erceived discrepancies between coders were discussed until con-
ensus was reached and the coding tree was ﬁnalized. Fourth, oneucational levels were deﬁned as ‘low’.
re often, etc.
author (DD) coded the three remaining transcripts using the ﬁnal
coding tree (Supplementary ﬁle C) and discussed her ﬁndings with
IK. All transcripts and codes were imported into NVivo software
(version 10, http://www.qsrinternational.com/) to enable system-
atic comparisons between different countries. We followed the
COREQ-checklist when writing this paper [17].
3. Results
In total, 41 people participated in six FGDs (Table 1). The median
age ranged from 40 (Sweden) to 47 (The Netherlands). Approx-
imately half of the participants were female. Lower and higher
educated people participated in each FGD.
The results are presented according to the themes that emerged
from the data and were used in the ﬁnal coding tree (Supplemen-
tary ﬁle C). Representative quotations for each theme were selected
to illustrate the results. If a quotation characterizes a minority opin-
ion, it is indicated. The quotations are numbered; an additional label
refers to the FGD ID.
3.1. Pandemic outbreak
Participants of all countries argued that their degree of concern
for a new disease would depend on the mode and speed of transmis-
sion. They also would want to know the consequences of a disease,
especially if potentially fatal, before deciding to take preventive
measures or not. Often, comparisons with previous communicable
disease outbreaks were made:
‘I think it is all about this danger. If there is to be a new swine ﬂu,
maybe you will not actually get vaccinated, because you think it’s
not that dangerous. But if there is an Ebola epidemic. . .’  (Q1SE1).
Dutch participants discussed that there would be no immunity
for an outbreak with a new virus, thus resulting in uncertainty
regarding the course of the disease. Swedish participants reasoned
that they would experience the threat of a new disease as severe
because they live in such a safe country:
‘We  do not have many other dangerous things to compare [the
disease] with, so small things become dangerous to us’ (Q2SE1).
Participants stated that they would weigh the threat of a new
disease within the context of their own  health status. Except for
those who belong to a risk group (diabetes, asthma), most partic-
ipants expected a low infection risk, e.g. thanks to healthy eating
and living, and good personal hygiene. Participants considered
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nformation about the health status of infected people important,
specially when also young and healthy people are infected,
ince this might change their perceived susceptibility. In addition,
he proximity of cases was considered important; the closer
he physical distance or the emotional relationship with a case,
he higher the level of perceived susceptibility. However, it was
emarked that proximity would be especially important in case of
 severe disease. If relatives fell ill and the disease was  not severe,
articipants did not intend to take safety measures. Most partic-
pants considered it wise to avoid visiting countries whit many
eople infected. Dutch and Swedish participants expressed their
orry that communicable diseases might spread more rapidly
owadays:
‘And now we move so incredibly easily: we ﬂy and sail across the
world. It can spread so easily’ (Q3SE1).
In one of the Dutch groups it was put forward that lack of herd
mmunity due to large groups of unvaccinated people [e.g. in the
o called ‘Bible belt’ in The Netherlands] might increase the risk of
etting the disease. Polish participants did not discuss perceived
eriousness of the disease and perceived susceptibility to the dis-
ase frequently.
.2. Vaccination
Across all countries, preventing the disease or reducing the
everity of its symptoms was considered the most important ben-
ﬁt of vaccines. Participants stated that the need for an effective
accine would be higher when a disease was perceived as more
erious. Anticipated regret made Dutch participants less hesitant
o get vaccinated (Q4), even if the effectiveness of the vaccine was
nclear.
‘Doing something is better than doing nothing. . . if something is
available you need to try it’ (Q4NL1).
Several Swedes expressed that getting vaccinated would not
nly be beneﬁcial for themselves but would also prevent them from
nfecting other people. Polish participants however were sceptical
bout the availability and quality of the vaccines in their country:
‘Still you have to consider the fact that even if you got a loan just to
get vaccinated, there probably wouldn’t be any vaccines available
in Poland, as usual’ (Q5PL2).
[Participant 1] ‘Don’t you get this impression, which I have, that
they [‘like France, Denmark, the West’] get better vaccines while
we get just the worst sort?’. [Participant 2] ‘Yes’. [Participant 3]
‘They get the ﬁrst grade while we get the fourth grade. We  import
it, so we get the leftovers’ (Q6PL2).
Several participants were opposed to vaccination in general as
hey believed it is healthiest if a body clears the virus without taking
rugs:
‘Why protect yourself against everything, while, in my opinion, it’s
more beneﬁcial to have the disease and ﬁght it yourself’ (Q7NL2).
The most common view however was to weigh potential bene-
ts and barriers of the vaccine against the threat of the disease:
‘What’s worse? Getting very sick and dying, or suffering from side
effects? You do have to make a choice’ (Q8NL1).
In general, the more severe the disease was seen, the less impor-
ant the barriers to vaccination were considered:‘I got vaccinated against ﬂu once and it’s taken a great toll on me.
I had high fever and headaches for three days. . . though if my life
was in danger.  . . I’d get vaccinated’ (Q9PL1).e 34 (2016) 803–808 805
Participants displayed concerns about the safety of the vaccine
due to the acute situation of a new pandemic, and limited time to
produce and test vaccines and their safety:
‘It will probably go damn fast, and they will not have time to test it.
And therefore we will have no clue about the possible side effects’
(Q10SE1).
Dutch participants expected their government to only introduce
vaccines if they were considered safe:
‘I do not expect the government to introduce a vaccine if they do
not trust it themselves, or if they do not have insights into the side
effects’ (Q11NL1).
Across all countries, costs of the vaccine appeared to be a strong
motivator in favour or against vaccination. Some participants stated
that the price of a vaccine should not matter because life is precious,
while others suggested that a vaccine should be available for the
whole population and thus provided for free (e.g. by the govern-
ment) (Q12, Q13). However, Polish participants did not believe that
providing a vaccine for free would happen in their country (Q14).
[Participant 1] ‘I think that if we  have something so digniﬁedly
called public health, we should make it free’. [Participant 2] ‘I think
so too’. [Participant 3] ‘I think so too, not everyone can spare a
hundred and ﬁfty Swedish Kronor’ (Q12SE1).
‘The costs are, in my opinion, the responsibility of the government.
The government should simply protect its people, without putting
a price tag on it’ (Q13NL1).
‘We  would see the Prime Minster or the Minster of Health, who
would tell us that the Polish government has decided to buy this
vaccine and to provide it to us for free [laughs], which we wouldn’t
believe’ (Q14PL1).
3.3. Social inﬂuences
Across all FGDs, it was  expected that the new disease and vac-
cination would be discussed extensively by traditional mass media
and on the Internet. Participants also frequently mentioned that
this kind of information should be approached critically and that
the source of information would really matter. One similar message
disseminated across all media would be considered as more reli-
able. In general, Swedish participants were most trustful towards
the national media (Q15), although some were critical (Q16).
‘We  have serious news reports, what is said in the news that is true’
(Q15SE1).
‘I was very sceptical of all the media pressure, and how they pointed
out people, saying they were not showing solidarity because they
did not get vaccinated, that everyone has to do it’ (Q16SE1).
It was stated in the Dutch discussions that to prevent public
panic, the government is expected to spread complete and trust-
worthy information as early in the pandemic as possible. Both Poles
and Swedes agreed that in case of a pandemic a representative
expert needs to step forward with the truth regarding the disease
and vaccination (Q17), although Poles questioned the availability
of such a person with that level of power and knowledge (Q18).
‘You have to hope and believe that the medical community will step
forward and honestly declare that it is safe, or that forty percent
can experience side effects’ (Q17SE2).[Participant 1] ‘So it’s reliable knowledge provided by someone
who’s competent’.  [Participant 2] ‘We  have no such authorities’.
[Participant3] ‘All the good professors, specialists moved to the
West’ (Q18PL2).
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Swedish participants considered the advice of relatives help-
ul in the decision about vaccination, while Polish participants did
ot:
‘We  [Polish people] might discuss it with someone, but everyone
makes such decisions on their own’ (Q19PL1).
The majority of Dutch participants expected to be personally
nvited by their general practitioner should they belong to a target
roup for vaccination:
‘I think that if I belonged to the target group, I would be invited
automatically by my general practitioner’ (Q20NL1).
In the Dutch and Swedish discussions participants suggested
hat they would contact people who already have been vaccinated,
o learn from their experience. However, participants were unsure
f those opinions would alter their decision. Participants mentioned
hat seeing friends or family suffer from the disease, would make
hem feel not only more susceptible to the disease, but also more
illing to get vaccinated:
‘I think that if someone close to me  or an acquaintance of mine died
of this disease, then it would decidedly make me get vaccinated
faster’ (Q21PL2).
The vaccination decision of quite some Dutch and Swedish par-
icipants would be inﬂuenced by the vaccination behaviour of the
ajority of their peers. Although some stated that revising their
pinion would depend on the number of and their relation with
accinated peers:
‘If everyone in your vicinity gets vaccinated, it is clear that it will
affect my decision. Then I will begin to wonder: should I really
ignore this?’ (Q22SE2).
.4. Population characteristics
It was mentioned by Swedish participants that during the
1N1 pandemic applying preventive measures was an automatic
esponse to the government’s call to get vaccinated, and that it was
n exception if one did not get vaccinated. They concluded that
hey were a generally risk aware, obedient, and very serious and
quality focused population:
‘It was true that the authorities stepped forward and told everyone
to get vaccinated. It was almost a command. You felt a bit guilty if
you did not do it, I think’ (Q23SE2).
‘We  [the Swedes] are quick to agree with each other, and then
we go home and grumble a little on our own. It’s a mental-
ity. We  are such herd animals; we do what everyone else does’
(Q24SE2).
‘We  want to do the right thing. When you are sitting in your car,
you should wear your seat belt. And if someone says that we will all
get sick, so now you should take a vaccine, then I take that vaccine’
(Q25SE2).
Polish participants mentioned being sceptical and reluctant
egarding vaccines and to be somewhat lacking in trust in doctors
nd the production process of vaccines:
‘I think they [‘conscious societies’, Norway is given as an
example] would obediently arrive for the vaccination, and they
wouldn’t hesitate. Whereas here [in Poland], people would start
to speculate just like we’re speculating now. Should we  do it,
or maybe it’s not worth it, or maybe the devil’s in the detail’
(Q26PL1).
‘Abroad everyone trusts doctors. It’s scary in a way. They have a
completely different attitude to doctors’ (Q27PL1).e 34 (2016) 803–808
3.5. Prior contact with similar diseases or vaccinations
Participants frequently referred to their experience with the
Inﬂuenza A/H1N1 2009 pandemic throughout the discussions,
also without the moderators introducing this topic. Dutch and
Swedish participants stated that due to their experience with the
H1N1 pandemic they would perceive any new disease as less
serious (Q28). Additionally, Swedish participants were sceptical
regarding the safety of vaccines because of the debate concern-
ing narcolepsy as a side effect of the 2009 pandemic vaccine
(Q29).
‘The risk when a new one [a new outbreak] comes.  . . Many may
think that it is exaggerated, like the swine ﬂu was’ (Q28SE2).
‘But this [debating about the safety of vaccines] is a new phe-
nomenon. Before the swine ﬂu came, we had never had this debate.
People have been vaccinated for who knows how many years’
(Q29SE2).
Participating Poles reﬂected positively on their governments’
decision not to buy the pandemic vaccine:
‘Well, there was this propaganda to get vaccinated. Of course there
was! There was propaganda all around the world. But it was limited
in Poland and that’s good, because it turned out we were the only
country in Europe that didn’t lose face then’ (Q30PL1).
In addition, experiences with a previous pandemic or seasonal
ﬂu may  affect choices to get vaccinated for a new disease, in these
cases positively:
‘My neighbour, a healthy boy of 13 years old, died of it [the Hong
Kong ﬂu]. In my opinion, it is not relevant that there is a chance
that the shot doesn’t work or that the outbreak will not end in an
epidemic. . . if there are no horrible stories about it [the vaccine],
I’ll take the shot’ (Q31NL1).
‘I had severe ﬂu complications several years ago. I ended up in the
hospital, it was horrible. A disease like that makes you change the
way you think [regarding vaccination]’ (Q32PL2).
3.6. Health authorities
Many participants put forward that doctors do not always agree
on the use of preventive measures during pandemics. National
Public Health Institutes were frequently mentioned as being trust-
worthy and reliable sources of information during Dutch (Q33) and
Swedish discussions, but not mentioned in the Polish discussions.
Instead, participants complained about the status of the public
health system in Poland (Q34).
If the outbreak is as severe as you describe just now, the RIVM
[National Institute for Public Health and the Environment in The
Netherlands] needs to play an active role, and inform us, instead
of us being dependent on subjective information’ (Q33NL2).
‘Prevention is more common there [in the West of Europe]. Maybe
they feel protected by the state more. We  don’t have that comfort’
(Q34PL1).
Polish participants were sceptical and distrustful when dis-
cussing their government, while the Swedish groups frequently
discussed their trust in government and the tendency to obey the
government, in spite of the decrease in trust since the H1N1 pan-
demic (Q35, Q36). They also mentioned the lack of trust in the
government elsewhere.‘You were really taken by surprise: My God, the state has given
us something that was not good. You’re not used to it, after all’
(Q35SE2).
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‘During the swine ﬂu days, the initial stand on the vaccine was:
Everyone should take it, and it’s safe, we’re all going to die, so
you have to get vaccinated. And then suddenly it changed: No,
no, Sweden has signed an agreement about this vaccine. We  [the
Swedish nation] had to buy it, which meant that they [the phar-
maceutical companies] wanted to sell it, and then it turned out
that it had not actually been tested. I think that is crazy’ (Q36SE2).
All groups discussed that people would want to make money
n new vaccines. These expectations inﬂuenced participants’ opin-
on on getting vaccinated negatively, although several Dutch and
wedish participants tended to trust and defend their govern-
ents:
I cannot keep on being so terribly sceptical. . . I have decided that
there are some government bodies that you trust. Otherwise I would
probably feel that there is no point that they exist’ (Q37SE1).
In both Dutch discussions, the advantages of international coop-
ration regarding the outbreak and vaccination were put forward.
. Discussion
We  explored public opinion and attitudes regarding vaccina-
ion during future pandemics and possible national differences by
onducting FGDs in three European countries: The Netherlands,
oland and Sweden. Participants stated that they would base their
accination decision on trade-offs between perceived beneﬁts and
arriers of the vaccine, also taking into account the seriousness
f a new pandemic outbreak. Except for those who belong to a
isk group, most participants in the present study expected a low
nfection risk, resulting in a lower willingness to get vaccinated.
 questionnaire study on seasonal Inﬂuenza vaccination coverage
nd reasons to refrain among high-risk persons in four European
ountries, including Poland and Sweden [18] showed that indi-
iduals did not perceive themselves as susceptible to seasonal
nﬂuenza either. During future outbreaks, it is therefore necessary
o provide the public with information regarding the health status
f ﬁrst cases, especially when also young and healthy people are
nfected, with information about the general level of susceptibil-
ty and a speciﬁcation of which groups are considered vulnerable
nd are thus being targeted for vaccination. The displayed con-
erns regarding the safety of newly developed vaccines were also
bserved in a Canadian focus group study [4]; people were hesitant
o accept vaccines during future pandemics due to the perceived
ncertainties considering novel vaccines and seriousness of dis-
ase.
Importantly, some differences between European countries
ere observed that have implications for outbreak preparedness.
e did observe differences in adherence to social norms and rules.
hereas Swedish participants displayed a tendency to do the right
hing and to get vaccinated to protect others, this appeared much
ess prominent in the Dutch and Polish participants. In countries
here there is a culture to follow social norms, such as in Sweden,
ommunication might focus more on the social norm, e.g. by pro-
iding normative information, both descriptive (perception of the
roportion of people opting for vaccination) and injunctive (per-
eption of what is approved or disapproved by others) [19–21].
rust in health authorities (or lack thereof) has implications for out-
reak planning too. Dutch and Swedish participants displayed more
rust in both health professionals as well as in national governments
han Polish participants. This was also observed in a survey during
he Inﬂuenza A/H1N1 2009 pandemic [22]. These different levels of
rust have implications for the promotion of and response to pub-
ic health messages from national governments and their public
ealth agencies [23–26]. The lack of trust in e.g. statements issued
y the national government can be problematic, since this hase 34 (2016) 803–808 807
been linked to a reduction in vaccination behaviour [23,25,27,28].
It is important to build trust in the pre-outbreak phase, main-
tain trust during outbreaks and, if necessary, restore or further
develop trust after the pandemic ends [29,30]. To do so, reliable
and trusted local representatives of the medical community need
to communicate clear public health messages regarding the new
outbreak and preventive measures. Swedish participants indicated
that their experiences during the Inﬂuenza A/H1N1 2009 pan-
demic would reduce their tendency to accept vaccination advice.
These discussions may  be rooted in the Swedish government having
signed a contract with a pharmaceutical company to buy pan-
demic Inﬂuenza A/H1N1 vaccines years before the outbreak [31]
and the high incidence rates of narcolepsy following the Inﬂuenza
A/H1N1 2009 pandemic, suggesting an association with vaccina-
tion [32,33]. The seasonal Inﬂuenza vaccination coverage in Sweden
decreased since the Inﬂuenza A/H1N1 2009 pandemic; it was 65.8%
in 2008–2009 but decreased to 44.3% in 2012–2013 [34]. Com-
bined with the Polish participants being proud that their Minister
of Health had not bought vaccines during the Inﬂuenza A/H1N1
2009 pandemic, these ﬁndings conﬁrm what Börjesson et al. con-
cluded in 2013; previous experiences with outbreak situations play
a crucial role in public opinions and future behaviour. Our study
highlights that outbreak experiences differ between countries in
many dimensions: with regard to cultural differences, with regard
to government policies, and with regard to vaccination side effects
(narcolepsy in Sweden). These differences stress the need to adapt
communication strategies to local circumstances.
4.1. Strengths and limitations
Although efforts to include individuals of different gender,
age and educational level were successful, there might still be
responder bias; individuals who  participated might be particu-
larly interested in the topic. This paper provides an illustration of
opinions and attitudes regarding future pandemics and vaccination
among members of the general public in three different European
countries. Future research could also focus on opinions and atti-
tudes of health care workers across European countries because of
the example they represent for public opinion. Vaccination history
as well as intentions of the general public to be vaccinated are posi-
tively associated with recommendations by health care workers to
do so [35]. Conclusions drawn from this study should be considered
with some caution as the ﬁndings are based on a small number of
individuals, and may  therefore not be generalizable to populations
at large. In addition, we cannot exclude the possibility that some of
the observed differences relate to individual differences rather than
to differences between countries. However, as there is hardly any
research examining differences in opinions and attitudes regarding
pandemics and vaccination across Europe, our results can be seen
as a ﬁrst step in this process.
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